Meadow Creek Investment Management’s aTyr Pharma ATYR Stock Holding History

Meadow Creek Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$32K	Sell	8,988 -26	-0.3%	-$96	﹤0.01%	1290
2019 Q2	$46K	Hold	9,014	–	–	﹤0.01%	1286
2019 Q1	$69K	Hold	9,014	–	–	﹤0.01%	1242
2018 Q4	$63K	Hold	9,014	–	–	﹤0.01%	1211
2018 Q3	$103K	Hold	9,014	–	–	﹤0.01%	1221
2018 Q2	$115K	Hold	9,014	–	–	﹤0.01%	1163
2018 Q1	$334K	Hold	9,014	–	–	0.01%	807
2017 Q4	$442K	Hold	9,014	–	–	0.01%	698
2017 Q3	$637K	Hold	9,014	–	–	0.01%	536
2017 Q2	$435K	Hold	9,014	–	–	0.01%	632
2017 Q1	$442K	Sell	9,014 -1,558	-15%	-$71.2K	0.01%	571
2016 Q4	$318K	Buy	+10,572	New	+$434K	0.01%	615

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meadow Creek Investment Management's ATYR Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its aTyr Pharma (ATYR) stake by 0.29% in Q3 2019, selling an estimated $96 and leaving 8,988 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Meadow Creek Investment Management first reported a position in ATYR in Q4 2016 and has held it in 12 quarters since. The position peaked at $637K in Q3 2017. 19 funds tracked by Wall St. Rank hold ATYR as of Q3 2019.

Meadow Creek Investment Management held 8,988 shares of aTyr Pharma worth $32K as of Q3 2019.
Meadow Creek Investment Management sold 26 aTyr Pharma shares in Q3 2019, an estimated $96.
aTyr Pharma made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1290 holding.
Meadow Creek Investment Management first reported a position in aTyr Pharma in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's aTyr Pharma position peaked at $637K in Q3 2017.
19 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.